DK0902022T3 - Hidtil ukendte benzofuranonderivater og fremgangsmåde til deres fremstilling - Google Patents
Hidtil ukendte benzofuranonderivater og fremgangsmåde til deres fremstillingInfo
- Publication number
- DK0902022T3 DK0902022T3 DK98900226T DK98900226T DK0902022T3 DK 0902022 T3 DK0902022 T3 DK 0902022T3 DK 98900226 T DK98900226 T DK 98900226T DK 98900226 T DK98900226 T DK 98900226T DK 0902022 T3 DK0902022 T3 DK 0902022T3
- Authority
- DK
- Denmark
- Prior art keywords
- processes
- preparation
- derivatives
- new
- benzofuranone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/83—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/54—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1599197 | 1997-01-14 | ||
| JP22556597A JP3783810B2 (ja) | 1997-01-14 | 1997-08-08 | 新規ベンゾフラノン誘導体及びその製造方法 |
| PCT/JP1998/000090 WO1998030556A1 (fr) | 1997-01-14 | 1998-01-13 | Nouveaux derives de benzofuranone et procede d'elaboration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0902022T3 true DK0902022T3 (da) | 2003-11-24 |
Family
ID=26352227
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK98900226T DK0902022T3 (da) | 1997-01-14 | 1998-01-13 | Hidtil ukendte benzofuranonderivater og fremgangsmåde til deres fremstilling |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US6143779A (ja) |
| EP (1) | EP0902022B1 (ja) |
| JP (1) | JP3783810B2 (ja) |
| KR (1) | KR100293907B1 (ja) |
| CN (1) | CN1173964C (ja) |
| AT (1) | ATE246180T1 (ja) |
| AU (1) | AU717159B2 (ja) |
| CA (1) | CA2248953C (ja) |
| DE (1) | DE69816731T2 (ja) |
| DK (1) | DK0902022T3 (ja) |
| ES (1) | ES2203921T3 (ja) |
| HU (1) | HUP9901616A3 (ja) |
| IL (1) | IL126137A (ja) |
| NO (1) | NO319608B1 (ja) |
| NZ (1) | NZ331857A (ja) |
| PT (1) | PT902022E (ja) |
| RU (1) | RU2152391C1 (ja) |
| WO (1) | WO1998030556A1 (ja) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999012540A1 (fr) * | 1997-09-11 | 1999-03-18 | Snow Brand Milk Products Co., Ltd. | Remedes contre des maladies hormonales |
| US7465739B2 (en) | 2003-06-10 | 2008-12-16 | Solvay Pharmaceuticals B.V. | Compounds and their use in therapy |
| US7754709B2 (en) | 2003-06-10 | 2010-07-13 | Solvay Pharmaceuticals Bv | Tetracyclic thiophenepyrimidinone compounds as inhibitors of 17β hydroxysteroid dehydrogenase compounds |
| MX2007000606A (es) * | 2004-07-14 | 2007-06-25 | Johnson & Johnson | Arilidenos para el tratamiento de enfermedades mediadas por receptor alfa relacionado con estrogeno. |
| GB0513702D0 (en) | 2005-07-04 | 2005-08-10 | Sterix Ltd | Compound |
| WO2007100066A1 (ja) | 2006-03-02 | 2007-09-07 | Astellas Pharma Inc. | １７βＨＳＤｔｙｐｅ５阻害剤 |
| US8080540B2 (en) | 2006-09-19 | 2011-12-20 | Abbott Products Gmbh | Therapeutically active triazoles and their use |
| EP2193807A4 (en) | 2007-08-24 | 2012-09-12 | Univ Sapporo Medical | BINDING PROTEIN AT CYCLOSPORIN A |
| GB0722779D0 (en) | 2007-11-20 | 2008-01-02 | Sterix Ltd | Compound |
| US20090192147A1 (en) * | 2008-01-30 | 2009-07-30 | Wyeth | [a]-FUSED INDOLE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES |
| US20090298820A1 (en) * | 2008-05-28 | 2009-12-03 | Wyeth | 3-substituted-1h-pyrrolo[2,3-b]pyridine and 3-substituted-1h-pyrrolo[3,2-b]pyridine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses |
| WO2009155042A1 (en) * | 2008-05-28 | 2009-12-23 | Wyeth | 3-substituted-1h-indole compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses |
| US9540322B2 (en) | 2008-08-18 | 2017-01-10 | Yale University | MIF modulators |
| PE20110368A1 (es) * | 2008-08-18 | 2011-06-13 | Univ Yale | Moduladores de mif |
| JP5656233B2 (ja) | 2010-04-30 | 2015-01-21 | 国立大学法人 東京大学 | 抗がん剤 |
| CN118356425A (zh) * | 2018-01-22 | 2024-07-19 | 肯塔基大学研究基金会 | 半合成噢哢及其使用方法 |
| CN115925665B (zh) * | 2022-12-09 | 2024-06-25 | 中国药科大学 | 一种pde4抑制剂及其应用 |
| CN117756761B (zh) * | 2023-12-14 | 2024-06-21 | 酒泉亚佳化学有限公司 | 一种苯并呋喃酮衍生物及其制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3975380A (en) * | 1974-06-03 | 1976-08-17 | Smithkline Corporation | Substituted aurones |
| US5354861A (en) * | 1992-11-04 | 1994-10-11 | National University Of Singapore | 2-(benzyl)-3-arylbenzofurans as antitumour and hypocholesterolemic agents |
| JP3872834B2 (ja) * | 1996-03-04 | 2007-01-24 | 第一製薬株式会社 | メイラード反応抑制剤 |
-
1997
- 1997-08-08 JP JP22556597A patent/JP3783810B2/ja not_active Expired - Fee Related
-
1998
- 1998-01-13 RU RU98118569/04A patent/RU2152391C1/ru not_active IP Right Cessation
- 1998-01-13 KR KR1019980707198A patent/KR100293907B1/ko not_active IP Right Cessation
- 1998-01-13 PT PT98900226T patent/PT902022E/pt unknown
- 1998-01-13 CN CNB988001365A patent/CN1173964C/zh not_active Expired - Fee Related
- 1998-01-13 DK DK98900226T patent/DK0902022T3/da active
- 1998-01-13 CA CA002248953A patent/CA2248953C/en not_active Expired - Fee Related
- 1998-01-13 EP EP98900226A patent/EP0902022B1/en not_active Expired - Lifetime
- 1998-01-13 NZ NZ331857A patent/NZ331857A/en unknown
- 1998-01-13 US US09/142,666 patent/US6143779A/en not_active Expired - Fee Related
- 1998-01-13 IL IL126137A patent/IL126137A/en not_active IP Right Cessation
- 1998-01-13 ES ES98900226T patent/ES2203921T3/es not_active Expired - Lifetime
- 1998-01-13 AU AU53436/98A patent/AU717159B2/en not_active Ceased
- 1998-01-13 WO PCT/JP1998/000090 patent/WO1998030556A1/ja active IP Right Grant
- 1998-01-13 AT AT98900226T patent/ATE246180T1/de not_active IP Right Cessation
- 1998-01-13 DE DE69816731T patent/DE69816731T2/de not_active Expired - Fee Related
- 1998-01-13 HU HU9901616A patent/HUP9901616A3/hu unknown
- 1998-09-11 NO NO19984195A patent/NO319608B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2248953A1 (en) | 1998-07-16 |
| HUP9901616A3 (en) | 2001-05-28 |
| AU717159B2 (en) | 2000-03-16 |
| CN1173964C (zh) | 2004-11-03 |
| IL126137A (en) | 2006-08-01 |
| HUP9901616A1 (hu) | 2001-04-28 |
| NO319608B1 (no) | 2005-08-29 |
| PT902022E (pt) | 2003-12-31 |
| EP0902022A1 (en) | 1999-03-17 |
| JPH10259182A (ja) | 1998-09-29 |
| DE69816731T2 (de) | 2004-06-03 |
| WO1998030556A1 (fr) | 1998-07-16 |
| JP3783810B2 (ja) | 2006-06-07 |
| RU2152391C1 (ru) | 2000-07-10 |
| IL126137A0 (en) | 1999-05-09 |
| AU5343698A (en) | 1998-08-03 |
| KR100293907B1 (ko) | 2001-09-17 |
| NZ331857A (en) | 2000-02-28 |
| EP0902022A4 (en) | 2002-01-23 |
| DE69816731D1 (de) | 2003-09-04 |
| NO984195L (no) | 1998-10-26 |
| NO984195D0 (no) | 1998-09-11 |
| US6143779A (en) | 2000-11-07 |
| ATE246180T1 (de) | 2003-08-15 |
| CA2248953C (en) | 2003-09-09 |
| KR20000064582A (ko) | 2000-11-06 |
| EP0902022B1 (en) | 2003-07-30 |
| ES2203921T3 (es) | 2004-04-16 |
| CN1217719A (zh) | 1999-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0902022T3 (da) | Hidtil ukendte benzofuranonderivater og fremgangsmåde til deres fremstilling | |
| DK0766668T3 (da) | Fremgangsmåde til fremstilling af vandfrie og hydratformer af som antihistaminer anvendelige piperidinderivater, polymorfer og pseudo-morfer deraf | |
| BG108318A (en) | Carboxamide-substituted phenylurea derivatives and method for the production and use thereof as medicaments | |
| SE9600406D0 (sv) | Novel coompounds | |
| CY1107403T1 (el) | Μια μεθοδος δια την παρασκευη υπερινδοπριλης,των αναλογων ενωσεων αυτης και των αλατων αυτων με χρησιμοποιηση ενδιαμεσων ενωσεων 2,5-διοξο-οξαζολιδινης | |
| PT923554E (pt) | N-benzilpiperidina e derivados tetrahidropiridina | |
| NZ521681A (en) | Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis | |
| EA200000358A1 (ru) | Способ получения диарилпиридинов, полезных в качестве ингибиторов cox-2 | |
| NO984532D0 (no) | Nye tetralon- eller benzopyranonderivater og fremgangsmÕte for fremstilling derav | |
| DK546489D0 (da) | Thienopyridin-mevalonolactoner, fremgangsmaade til fremstilling heraf og farmaceutisk praeparat omfattende samme | |
| DK0428878T3 (da) | Benzocycloalkylaminopyridinaminer og beslægtede forbindelser, fremgangsmåde til deres fremstilling, mellemprodukter og deres anvendelse som lægemidler | |
| DE60227421D1 (de) | Rmazeutische zusammensetzung und verwendung davon | |
| ATE267832T1 (de) | Substanz gm-95, verfahren zu ihrer herstellung und ihre verwendung | |
| DK1000067T3 (da) | Thiazolobenzoheterocycliske forbindelser, deres fremstilling og lægemidler indeholdende forbindelserne | |
| NO20054418L (no) | Substituert benzoylureidopyridylpiperidin- og -pyrrolidinkarboksylsyrederivater, deres fremstilling og anvendelse | |
| NO20043047L (no) | Mellomprodukter for LHRH-antagonistsyntese, fremgangsmate for fremstilling derav og fremgangsmate for LHRH-antagonistfremstilling | |
| WO2002085877A3 (en) | Processes and intermediates for preparing benzyl substituted epoxides | |
| DK1235832T3 (da) | Precursorer for vitamin D, fremgangsmåde til fremstilling heraf og mellemforbindelser | |
| DK0677513T3 (da) | Octahydro-2-naphthalencarboxylsyrederivat, dets fremstilling og anvendelse | |
| WO2003087035A8 (en) | 2,5-bis-diamine-'1,4! benzoquinone derivatives for the treatment of alzheimer's disease a process for their preparation and intermediates therefor | |
| NO20031137D0 (no) | Fremgangsmåte for fremstilling av kirale forbindelser | |
| TR200001161A2 (tr) | 8-Siklopentil-6-etil-3-[ikame edilmiş]-5, 8-Dihidro-4H-1, 2, 3A, 7, 8-Pentaaza-As-Indasenlerin hazırlandığı işlem ve burada yararlı ara bağlar. | |
| MXPA04004537A (es) | Derivados de gabusectina, metodo para produccion de los mismos y uso de los mismos. | |
| RO116896B1 (ro) | Derivaţi pseudocarbaciclinici şi procedeu pentru prepararea acestora |